title: [Immune status estimation algorithm in irritable bowel syndrome patients with food intolerance].
abstract: OBJECTIVE
  To develop an algorithm for evaluation of the immune status in IBS patients with food intolerance.
  
  
  METHODS
  42 patients with IBS were observed. The diagnosis is based Rome III criteria. Determination of the concentration of serum allergen-IgG-antibodies to food allergens, IgG, IgA, IgM, IgE and immunoregulatory substances IL-5, TGF β1, IL-10, IL-4 IL-2, IL-13 were determined by enzyme immunoassay. All the patients received rotational diet therapy based on immunoassay data in addition to medical treatment of the basis disease. The control group comprised 15 healthy individuals.
  
  
  RESULTS
  Food intolerances basically to foods proteinaceous was diagnosed in 25 patients with IBS (59.5% of cases). The effectiveness of diet therapy was 68% (17 patients). Analysis of clinical and laboratory data revealed that the implementation of food intolerance in patients with IBS reducing the levels of IL-10 and TGFβ1. An effective rotational diet of food intolerance in IBS patients had significantly (p < 0.05) increase IgA levels.
  
  
  CONCLUSIONS
  Food intolerance in IBS patients characterized an increased synthesis of allergen-specific IgG antibodies, insufficient production of anti-inflammatory immunoregulatory substances IL-10 and TGFβ1, and intact cytokines IL-2, - 4, - 5, - 13, IgG and IgM in serum. Efficiency rotary diet in patients with IBS is accompanied by positive clinical dynamics, increase levels of anti-inflammatory substances and serum IgA.
authors.forename: T B
authors.initials: TB
authors.lastname: Sentsova
authors.forename: I V
authors.initials: IV
authors.lastname: Vorozhko
authors.forename: V A
authors.initials: VA
authors.lastname: Isakov
authors.forename: S V
authors.initials: SV
authors.lastname: Morozov
authors.forename: A K
authors.initials: AK
authors.lastname: Shakhovskaia
mesh_terms: D000328:Adult; D000465:Algorithms; D016207:Cytokines / Q000097:blood* / Q000276:immunology; D004044:Dietary Proteins / Q000009:adverse effects* / Q000276:immunology; D005260:Female; D005512:Food Hypersensitivity / Q000097:blood / Q000201:enzymology / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007124:Immunoenzyme Techniques; D007070:Immunoglobulin A / Q000097:blood / Q000276:immunology; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D007075:Immunoglobulin M / Q000097:blood / Q000276:immunology; D007136:Immunoglobulins / Q000097:blood* / Q000276:immunology; D007413:Intestinal Mucosa / Q000276:immunology / Q000294:innervation / Q000378:metabolism; D043183:Irritable Bowel Syndrome / Q000097:blood / Q000201:enzymology / Q000276:immunology*; D008297:Male; D010950:Plasma Cells / Q000201:enzymology / Q000276:immunology; D012799:Sialyltransferases / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase
chemical_list: D016207:Cytokines; D004044:Dietary Proteins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D012799:Sialyltransferases; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase